Development of Standardized Fetal Progenitor Cell Therapy for Cartilage Regenerative Medicine: Industrial Transposition and Preliminary Safety in Xenogeneic Transplantation.
- DOI
- 10.3390/biom11020250
- Published
- 2021 Feb 9
- Container
- Biomolecules
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/biom11020250,
title = {Development of Standardized Fetal Progenitor Cell Therapy for Cartilage Regenerative Medicine: Industrial Transposition and Preliminary Safety in Xenogeneic Transplantation.},
author = {Laurent A and Abdel-Sayed P and Ducrot A and Hirt-Burri N and Scaletta C and Jaccoud S and Nuss K and Roessingh ASB and Raffoul W and Pioletti D and Rechenberg BV and Applegate LA and Darwiche S},
year = {2021},
journal = {Biomolecules},
doi = {10.3390/biom11020250},
url = {https://doi.org/10.3390/biom11020250}
}RIS
TY - JOUR TI - Development of Standardized Fetal Progenitor Cell Therapy for Cartilage Regenerative Medicine: Industrial Transposition and Preliminary Safety in Xenogeneic Transplantation. AU - Laurent A AU - Abdel-Sayed P AU - Ducrot A AU - Hirt-Burri N AU - Scaletta C AU - Jaccoud S AU - Nuss K AU - Roessingh ASB AU - Raffoul W AU - Pioletti D AU - Rechenberg BV AU - Applegate LA AU - Darwiche S PY - 2021 JO - Biomolecules DO - 10.3390/biom11020250 UR - https://doi.org/10.3390/biom11020250 ER -
APA
A, L., P, A., A, D., N, H., C, S., S, J., K, N., ASB, R., W, R., D, P., BV, R., LA, A., & S, D. (2021). Development of Standardized Fetal Progenitor Cell Therapy for Cartilage Regenerative Medicine: Industrial Transposition and Preliminary Safety in Xenogeneic Transplantation.. Biomolecules. https://doi.org/10.3390/biom11020250
Source records
- pubmed · retrieved 2026-11-10T15:50:57.595Z